CRISPR and HIV

Excision BioTherapeutics reported positive interim clinical data for its HIV therapeutic candidate EBT-101 at this year's European Society for Gene &...

A one-shot CRISPR cure for HIV may be in sight with a new approach that eliminated replication-competent virus in 58% of infected mice. The method...

A recent study reports the first ever application of base editing to protect immune cells against HIV infection. This is achieved without introducing...

Researchers at Texas Biomedical Research Institute in San Antonio, Texas have developed a novel strategy to inhibit human immunodeficiency virus (HIV)...

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

This week, we look at a CRISPR-based therapy for HIV that has just passed the IND approval stage, and will soon be tested in a Phase 1/2 clinical...

Results from the first clinical trials using CRISPR in persons have been reported. The early first attempts showed safety and feasibility but did not...